简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-05-18 14:59 New data and analyses confirm the efficacy and safety of OFEV® (nintedanib*) for the treatment of IPF beyond 52 weeks and for distinct subgroups
2015-05-15 15:03 Arcadia Biosciences, Inc. Announces Pricing of Initial Public Offering
2015-05-14 16:40 Telerx Launches CaseTrack360 Customer Engagement Solution
2015-05-14 15:24 Smiths Medical to Sponsor US and Global Symposiums, Exhibitor Theater Presentations at Upcoming Conferences
2015-05-14 14:57 DuBiotech Welcomes Germany’s B.Braun
2015-05-14 14:40 Boehringer Ingelheim showcases expanding presence in lung cancer at ASCO 2015 with new data including presentation of afatinib* overall survival results for squamous cell carcinoma of the lung
2015-05-14 10:15 EOS imaging Expands Presence in Asia with First Installation in Hong Kong
2015-05-14 10:00 Merck and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
2015-05-14 09:47 First patient enrolled in dabigatran study comparing anticoagulation strategies during AF ablation
2015-05-13 10:00 ResolutionMD Receives Certification for Web and Mobile Diagnosis in Hong Kong
2015-05-12 14:53 International Scientists Appeal to U.N. to Protect Humans and Wildlife from Electromagnetic Fields and Wireless Technology
2015-05-12 14:00 Takeda Announces First Patient Enrolled in Global Phase 3 Study of Ixazomib as Maintenance Therapy for Newly Diagnosed Multiple Myeloma
2015-05-08 14:36 Applications Open for 2015 Terumo BCT Advancing Apheresis Award
2015-05-06 10:41 Teva Provides Additional Detail on Proposed Acquisition of Mylan
2015-05-06 10:03 Final Countdown to World’s Largest Integrated Healthcare Industry Event tHIS
2015-05-05 17:15 Larry Horn of MPEG LA to Present at NewYorkBIO 25th Anniversary Conference on May 5
2015-05-05 14:06 Quintiles Establishes Bioanalytical Laboratory in Europe
2015-05-04 17:49 Quintiles Named to InformationWeek Elite 100
2015-05-04 15:24 Arcadia Biosciences, Inc. Commences Initial Public Offering
2015-05-04 15:07 Teva Sends Letter to Mylan Board